Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

Name: Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age
License: Public Domain

Dynavax Technologies Corporation

ClinicalTrials.gov · Datasets · License: Public Domain

prevention of pneumonic plague resulting from aerosol exposure to yersenia pestis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 279562
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.